Modeling the effects of prebiotic interventions on luminal and mucosa-associated gut microbiota without and with Clostridium difficile challenge in vitro

Prebiotics can modulate the gut microbial community composition and function for improved (gut) health and increase resilience against infections. <i>In vitro</i> models of the gut facilitate the study of intervention effects on the gut microbial community relevant to health. The mucosa-associated gut microbiota, which thrives in close contact with the host plays a pivotal role in colonization resistance and health. Therefore, we here introduce the Mi-screen, an experimental approach implementing a 96-well plate equipped with a mucus agar layer for the additional culturing of mucosa-associated microbiota <i>in vitro</i>. In this study, we screened the effects of 2'-Fucosyllactose (2'-FL), fructooligosaccharides (FOS), and inulin within a complex microbiota without and with infection with the <i>C. difficile</i> strains ATCC 43599 (Ribotype 001) or ATCC BAA-1870 (Ribotype 027). We analyzed the microbial community composition and short-chain fatty acid levels after 48 h of incubation. The inclusion of an additional substrate and surface in the form of the mucus agar layer allowed us to culture a microbial richness ranging between 100-160 in Chao index, with Shannon indices of 5-6 across culture conditions, indicative of a microbial diversity of physiological relevance. The mucus agar layer stimulated the growth of characteristic mucosa-associated bacteria such as <i>Roseburia inulinovorans</i>. The prebiotic interventions affected luminal and mucosal microbial communities cultured <i>in vitro</i> and stimulated short-chain fatty acid production. FOS, inulin and 2'-FL promoted the growth of <i>Bifidobacterium adolescentis</i> within the mucosa-associated microbiota cultured <i>in vitro</i>. When spiking the untreated conditions with pathogenic <i>C. difficile</i>, the strains thrived within the luminal and the mucosal sample types, whereas prebiotic treatments exhibited inhibitory effects on <i>C. difficile</i> growth and prevented colonization. In conclusion, the Mi-screen facilitates the screening of luminal and mucosa-associated gut microbial community dynamics <i>in vitro</i> and therefore fills an important gap in the field of <i>in vitro</i> modeling.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2024-08-09
DOI
https://doi.org/10.3389/fnut.2024.1403007
Citations
6
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modeling the effects of prebiotic interventions on luminal and mucosa-associated gut microbiota without and with Clostridium difficile challenge in vitro

Margreet Heerikhuisen, J.M.B.M. van der Vossen, Anita Ouwens, Maria Wiese et al.
6 citations
Frontiers in Nutrition
Gut microbiota and health
1.40
article

Modeling the effects of prebiotic interventions on luminal and mucosa-associated gut microbiota without and with Clostridium difficile challenge in vitro

Margreet Heerikhuisen, J.M.B.M. van der Vossen, Anita Ouwens, Maria Wiese, Elwin Verheij, Michelle van der Wurff, Bowien van Leijden
article en
6 citations

Abstract

Prebiotics can modulate the gut microbial community composition and function for improved (gut) health and increase resilience against infections. <i>In vitro</i> models of the gut facilitate the study of intervention effects on the gut microbial community relevant to health. The mucosa-associated gut microbiota, which thrives in close contact with the host plays a pivotal role in colonization resistance and health. Therefore, we here introduce the Mi-screen, an experimental approach implementing a 96-well plate equipped with a mucus agar layer for the additional culturing of mucosa-associated microbiota <i>in vitro</i>. In this study, we screened the effects of 2'-Fucosyllactose (2'-FL), fructooligosaccharides (FOS), and inulin within a complex microbiota without and with infection with the <i>C. difficile</i> strains ATCC 43599 (Ribotype 001) or ATCC BAA-1870 (Ribotype 027). We analyzed the microbial community composition and short-chain fatty acid levels after 48 h of incubation. The inclusion of an additional substrate and surface in the form of the mucus agar layer allowed us to culture a microbial richness ranging between 100-160 in Chao index, with Shannon indices of 5-6 across culture conditions, indicative of a microbial diversity of physiological relevance. The mucus agar layer stimulated the growth of characteristic mucosa-associated bacteria such as <i>Roseburia inulinovorans</i>. The prebiotic interventions affected luminal and mucosal microbial communities cultured <i>in vitro</i> and stimulated short-chain fatty acid production. FOS, inulin and 2'-FL promoted the growth of <i>Bifidobacterium adolescentis</i> within the mucosa-associated microbiota cultured <i>in vitro</i>. When spiking the untreated conditions with pathogenic <i>C. difficile</i>, the strains thrived within the luminal and the mucosal sample types, whereas prebiotic treatments exhibited inhibitory effects on <i>C. difficile</i> growth and prevented colonization. In conclusion, the Mi-screen facilitates the screening of luminal and mucosa-associated gut microbial community dynamics <i>in vitro</i> and therefore fills an important gap in the field of <i>in vitro</i> modeling.

Frontiers in NutritionVol. 11
Netherlands Organisation for Applied Scientific Research (NL)
Openalex Percentile: Top 19%
Gut microbiota and health
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.